Skip to content

Critical Evaluation of a Targeted Point of Care (POC) ROTEM (Registered Trademark) and Multiplate (Registered Trademark) Guided Coagulation and Haemostasis Management Programme in Cardiac Surgical Patients

Critical Evaluation of a Targeted Point of Care (POC) ROTEM (Registered Trademark) and Multiplate (Registered Trademark) Guided Coagulation and Haemostasis Management Programme in Cardiac Surgical Patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12614000182695
Acronym
N/A
Enrollment
200
Registered
2014-02-17
Start date
2015-06-29
Completion date
2017-03-01
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

There is an increasing body of evidence that the adoption of point of care (POC) guided coagulation and haemostatic management algorithms in the cardiac surgical patient population results in improved outcomes. We aim to critically evaluate our POC programme at the Gold Coast University Hospital (GCUH). In addition, we aim to evaluate the prognostic importance of baseline and perioperative humeral factors relating to haem catabolism (bilirubin/carboxy haemoglobin) in modulating haemostatic function and predicting post-operative outcomes in patients undergoing cardiac surgery

Interventions

ROTEM / Multiplate coagulation assessment and product transfusion protocol. At 4 predefined time points a ROTEM/Multiplate panel of tests will be analysed: 1. Pre-operatively 2. 30 mins before coming off Cardiopulmonary Bypass 3. 10 mins after coming off CPB and after Protamine 4. On admission to ICU post-operatively At each of these time points blood product replacement will be guided by the results. There is a predefined and validated algorithm. In addition further tests will be done 10 min

ROTEM / Multiplate coagulation assessment and product transfusion protocol. At 4 predefined time points a ROTEM/Multiplate panel of tests will be analysed: 1. Pre-operatively 2. 30 mins before coming off Cardiopulmonary Bypass 3. 10 mins after coming off CPB and after Protamine 4. On admission to ICU post-operatively At each of these time points blood product replacement will be guided by the results. There is a predefined and validated algorithm. In addition further tests will be done 10 minutes after any haemostatic intervention. Further testing can be done at clinician discretion - i.e. In the presence of on-going bleeding further testing will be performed. Testing will cease once there is no further evidence of on-going bleeding .

Sponsors

Gold Coast University Hospital Critical Care Research Group
Lead SponsorHospital

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

All patients undergoing cardiac surgery

Exclusion criteria

Age < 18 years

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026